CLINICAL_TRIALS
trial_result
· 2023-06-02
Clinical Trial Update: Open-label Extension to Protocol 1042-0500 [Phase 2]
Summary
An open-label extension to Protocol 1042-0500 (Phase 2) in infantile spasms was terminated. Results from the extension were posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marinus Pharmaceuticals | Conditions: Infantile Spasms | Phase 2 | Status: TERMINATED | Results posted: 2023-06-02